| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |